Generic Medicine Labelling Packaging Pharmaceutical Companies 
European Pharmaceutical Review
MARCH 14, 2023
This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”
pharmaphorum
MAY 26, 2022
Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.
Expert insights. Personalized for you.
80 
Let's personalize your content